Professor, Internal Medicine, Mayo Medical School
Nephrology
Dr. James M. Gloor, MD
|
|
Give Review
James M. Gloor works in the field of Nephrology. Dr. James M. Gloor is a published doctor. He has 81 publications published. The most current publication "Lupus nephritis in children." James Gloor accepts Medicare.
Publications
- Five-year outcomes in living donor Kidney transplants with a positive crossmatch.
- MR elastography in renal transplant patients and correlation With renal allograft biopsy: a feasibility study.
- The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo.
- The utility of comprehensive assessment of donor specific anti-HLA antibodies in the clinical management of pediatric Kidney transplant recipients.
- The effect of coronary angiography on Renal function in preemptive Renal transplant candidates.
- The (re)emergence of B cells in organ transplantation.
- Significance and implications of capillaritis during acute rejection of Kidney allografts.
- Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.
- Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
- Rituximab for successful management of probable pediatric catastrophic antiphospholipid Syndrome.
- Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
- The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
- A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible Kidney transplantation.
- Conquering absolute contraindications to transplantation: positive-crossmatch and ABO-incompatible Kidney transplantation.
- Patient and graft outcomes from older living Kidney donors are similar to those from younger donors despite lower GFR.
- ABO-incompatible Kidney transplantation.
- Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor Kidney transplantation.
- Pancreas-after-Kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-Kidney transplantation.
- Decline in native Renal function early after bladder-drained pancreas transplantation alone.
- Influence of surveillance Renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy.
- ABO-incompatible Kidney transplantation using both A2 and non-A2 living donors.
- Subclinical rejection in tacrolimus-treated Renal transplant recipients.
- Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
- Kidney transplantation without calcineurin inhibitors using sirolimus.
- Mechanisms of alloantibody production in sensitized Renal allograft recipients.
- The spectrum of antibody-mediated Renal allograft injury: implications for treatment.
- A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients With high levels of donor specific alloantibody.
- Living-donor Kidney transplantation at Mayo Clinic--Rochester.
- Blood pressure evaluation among older living Kidney donors.
- Kidney transplantation in the hyperimmunized patient.
- Blood pressure and renal function after Kidney donation from hypertensive living donors.
- ABO-incompatible Kidney transplantation with and without splenectomy.
- Complications, resource utilization, and cost of ABO-incompatible living donor Kidney transplantation.
- Sensitized Renal transplant recipients: current protocols and future directions.
- A Novel Mutation of LAMB2 in a Multigenerational Mennonite Family Reveals a New Phenotypic Variant of Pierson Syndrome.
- Steroid-free maintenance immunosuppression and ABO-incompatible transplantation.
- Terminal complement inhibition decreases antibody-mediated rejection in sensitized Renal transplant recipients.
- Bilateral native ureteral ligation without nephrectomy in the management of Kidney transplant recipients with native proteinuria.
- Identifying specific causes of Kidney allograft loss.
- The outcome of patients with nephrogenic systemic fibrosis after successful Kidney transplantation.
- The histology of solitary Renal allografts at 1 and 5 years after transplantation.
- Baseline donor-specific antibody levels and outcomes in positive crossmatch Kidney transplantation.
- Alloantibody levels and acute humoral rejection early after positive crossmatch Kidney transplantation.
- Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.
- Acute cellular rejection in a Renal allograft immediately following leukocyte engraftment after auto-SCT.
- Transplant glomerulopathy: subclinical incidence and association With alloantibody.
- Kidney transplantation in patients with antibodies against donor HLA class II.
- The effect of desensitization protocols on human splenic B-cell populations in vivo.
- Survival of patients on the Kidney transplant wait list: relationship to cardiac troponin T.
- Interpreting post-transplant proteinuria in patients With proteinuria pre-transplant.
- Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor Kidney transplantation.
- Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).
- Complete avoidance of calcineurin inhibitors in Renal transplantation: a randomized trial comparing sirolimus and tacrolimus.
- Transplant glomerulopathy.
- Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization With IVIG and rATG.
- Plasma exchange conditioning for ABO-incompatible Renal transplantation.
- Charcoal hemofiltration for hepatic veno-occlusive Disease after hematopoietic stem cell transplantation.
- Thymoglobulin induction decreases rejection in solitary pancreas transplantation.
- Cyclosporine elimination in the presence of TOR inhibitors: effects on Renal function, acute rejection, and safety.
- Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract Infection.
- Disseminated varicella infection in pediatric renal transplant recipients treated With mycophenolate mofetil.
- Lupus Nephritis in children.
- Proximal urinary diversion in the management of posterior urethral valves: is it necessary?
- Fetal Renal growth evaluated by prenatal ultrasound examination.
- Persistent severe hypertension in an infant With posterior urethral valves.
- Prenatally diagnosed ureterocele presenting as fetal bladder outlet obstruction.
- Prenatal maternal indomethacin use resulting in prolonged neonatal Renal insufficiency.
- Management of prenatally detected fetal hydronephrosis.
- Urinary tract anomalies detected by prenatal ultrasound examination at Mayo Clinic Rochester.
- The association of isolated mild fetal hydronephrosis With postnatal vesicoureteral reflux.
- Overcoming a positive crossmatch in living-donor Kidney transplantation.
- Accommodation in ABO-incompatible Kidney allografts, a novel mechanism of self-protection against antibody-mediated injury.
- Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor Kidney transplantation.
- Can a transplanted living donor Kidney function equivalently to its native partner?
- Early subclinical coronary artery calcification in young adults who were pediatric Kidney transplant recipients.
- Living donor Kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
- Kidney allograft fibrosis and atrophy early after living donor transplantation.
- ABO incompatible Kidney transplantation.
- Hand-assisted laparoscopic donor nephrectomy for pediatric Kidney allograft recipients.
- Antibody-mediated rejection following transplantation from an HLA-identical sibling.
Schools
Universidad Nacional Autonoma De Honduras Facultad De Ciencias Medicas
Mayo Grad School MedMayo Fndn
Msu Kalamazoo Center Med Stu
Conditions Treated
- Calcium Metabolism Disorders
- Chronic GlomeruloNephritis
- Chronic Kidney Diseases
- Diabetes With Renal Manifestations
- View All
Doctors Specialties
- Nephrology
- Pediatric Nephrology
Accepted Insurances
- Amerihealth
- Assurant Health
- Blue Cross Blue Shield
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Humana
- Medica
- Medicaid
- Medicare MCR
- Meritain Health
- NGS CoreSource
- United Healthcare
Education
-
University of Virginia -
Mayo School of Graduate Medical Education -
Michigan State University at Kalamazoo -
Universidad Nacional Autonoma de Honduras
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1215964986 | |
| NPPES Provider LastName | GLOOR | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 02852 | |
| NPPES Provider State | RI | |
| Specialty Description | General Practice | |
| Total Claim Count | 3280.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 114.0 | |
| Percent Opioid Claims | 3.48 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215964986 |
| Last Name Of The Provider | GLOOR |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Amit K. Ghosh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter G. Czarnecki, MD |
|
|
Dr. Latonya J. Hickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy W. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl L. Tran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hatem Amer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin L. Greer, MD |
|
|
Dr. Naim S. Issa, MD
This Doctor is OpenDoctor Recommended.
|